Speech-Language Pathologists in Flanders, NJ Accepting Medicare

6 Speech-Language Pathologists found. Showing 1 - 6

Miss Samantha Mae Bakelmun Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 182 Clover Hill Dr, Flanders, NJ 07836 Phone: 973-229-8689

Elizabeth Navas, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 293 Us Highway 206 Unit 10, Flanders, NJ 07836 Phone: 908-955-0071

Ms. Mary Jane Goldberg, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 285 Pleasant Hill Rd, Flanders, NJ 07836 Phone: 973-598-8506

Joleen Wiggins, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3 Kenneth Ter, Flanders, NJ 07836 Phone: 973-903-5943

Erin Shipley, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 44 Knollwood Rd, Flanders, NJ 07836 Phone: 201-841-5932

Alyxandra A Direnzo Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 114 Cloverhill Dr, Flanders, NJ 07836 Phone: 973-927-2201

News Archive

Life Expectancy with Disability is worse in European women than men

European women live longer than men, because of both biological and behavioural advantages, but women's longer lives are not necessarily healthy lives. Studies commented on by Dr Vannuzzo at the ESC Congress 2011, show that due to increase in tobacco and alcohol consumption in women, the gender gap is decreasing.

AdvanSource Biomaterials' polymer product lines comply with the guidelines of European Council Decision

AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced that its polymer product lines are compliant with measures applying to the processing of certain animal waste to protect against transmissible spongiform encephalopathies as set forth in European Council Decision 1999/534/EC.

GE report outlines new landscape for innovation in the 21st century

A first-of-its-kind report released today outlines a new landscape for innovation in the 21st century, placing an increased premium on addressing local needs, marshaling the creativity of individuals and smaller organizations, and forging strategic partnerships.

CHMP grants positive opinion to extend the use of Angiox to patients undergoing PCI

The Medicines Company announced today that the Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion applicable to all Member States of the European Union/European Economic Area that will extend the use of Angiox (bivalirudin) to include patients with heart attacks (so-called ST segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).

Read more Medical News

› Verified 8 days ago